Warwick Researchers to provide COVID-19 Intervention Modelling for East Africa (CIMEA)

20-Apr-2020 1:30 PM EDT, by University of Warwick

Newswise — · The rapid spread of SARS-CoV-2 (the virus that causes COVID-19) across the world poses a threat to all, but particularly, countries with the weakest health systems

· East Africa requires an epidemic response that optimally mitigates COVID-19 disease, and scientists from the School of Life Sciences at the University of Warwick are assisting this effort

· The scientists will provide evidence using bespoke modelling, to forecast the impact of different interventions that will support policy decisions

A £1m grant from the Wellcome Trust has enabled researchers from the School of Life Sciences at the University of Warwick, to work with East African countries in their emergency preparations for COVID-19 as the pandemic spreads across Africa.

The Wellcome Trust has announced £12m of grants to partnerships with the UK Department for International Development, in a bid to speed up global COVID-19 research and development, in order to help low and middle-income countries prepare for the pandemic.

£1m has been awarded to researchers at the School of Life Sciences and Mathematics Institute at the University of Warwick, who will be working with colleagues in Uganda and Kenya to help East Africa develop optimal control strategies for COVID-19.

The full list of researchers who are all in the Zeeman Institute at Warwick include: Professor James NokesProfessor Xavier Didelot, both from the School of Life Sciences at the University of Warwick, along with Professor Matt Keeling from the School of Life Sciences and the Mathematics Institute at Warwick, will work with Dr George Githinji from the KEMRI-Wellcome Trust Research programme in Kenya, and Professor Matthew Cotten from the MRC/ UVRI and LSHTM Uganda Research Unit.

COVID-19 cases have been recorded in almost all African countries and it’s imminent that East Africa will experience onward transmission, as SARS-CoV-2 virus spreads rapidly, meaning control will be difficult.

Researchers will support the emergency response through predictive modelling, incorporating known demographic population structures, age related contact patterns and existing mobile phone population movement data. In Uganda and Kenya they will collect epidemiological, genomic and behavioural data through health facility surveillance, household follow-up and contact studies. This will allow them to quantify uncertainties of SARS-CoV-2 virus epidemiology and contact patterns in well and unwell individuals, and under different social distance interventions.

Work will be done in close collaboration with partner institutes in East Africa (Kenya and Uganda), with other modelling and epidemiology groups in the Region, and in cooperation with government health ministries. This will ensure the modelling is tailored to each country setting and policy relevant questions are addressed, and hence results will be distributed rapidly to the relevant authorities, so that national plans for dealing with this public health emergency can benefit from predictions of the expected rate, distribution and extent of spread in countries throughout the region, and on the likely impact and feasibility of a range of interventions.

Professor James Nokes, from the School of Life Sciences, University of Warwick comments:
“We hope that by closely combining our efforts with in-country expertise in modelling, epidemiology, health economics and systems and vulnerability mapping we can develop models appropriate to each setting with results that will immediately feed into the policy making process to have the greatest impact.

“Our modelling code and analyses, and data including sequences, will be placed in the public domain in near real-time, in the hope that the project output can be widely adopted and also the evidence to policy links made will have lasting impact on the role of predictive modelling in supporting infectious disease control decisions making.”



Filters close

Showing results

110 of 5820
access_time Embargo lifts in 2 days
Embargo will expire: 15-Jun-2021 11:00 AM EDT Released to reporters: 14-Jun-2021 5:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Released: 14-Jun-2021 5:15 PM EDT
For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Johns Hopkins Medicine

In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 — the virus that causes COVID 19 — more than the standard two-dose regimen for people who have received solid organ transplants.

Newswise: Broadway1_DTLA_sz.lowres-768x512.jpg
Released: 14-Jun-2021 4:05 PM EDT
What’s Next: The Ongoing Urban Exodus
University of California, Irvine

Many employees have come to prefer working from home after being forced to do so more than a year ago when the pandemic started. By some estimates, at least one-quarter of employees will still be working remotely multiple days a week at the end of 2021. For those whose jobs allow it, being untethered from the office might mean moving farther away from it – by a few miles or a few hundred.

Newswise: 267701_web.jpg
Released: 14-Jun-2021 2:50 PM EDT
New model accounts for the effect of behavior changes to predict COVID-19 cases
Brown University

By adding behavioral components to an infectious disease model, Brown University researchers have developed a new modeling approach that captures the peaks and valleys in new COVID-19 cases seen over the past 16 months.

Newswise: Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Released: 14-Jun-2021 2:05 PM EDT
Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Keck Medicine of USC

June 15 is a banner day in California. Most COVID-19 statewide restrictions will be eliminated, including physical distancing and in many situations, mask mandates. How will life change and how will it stay the same? Keck Medicine of USC experts weigh in on what to expect next in the golden state.

access_time Embargo lifts in 2 days
Embargo will expire: 15-Jun-2021 8:00 AM EDT Released to reporters: 14-Jun-2021 11:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Jun-2021 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: California Reopening: Experts Say Keep Masks Handy
Released: 14-Jun-2021 10:35 AM EDT
California Reopening: Experts Say Keep Masks Handy
Cedars-Sinai

This week brings a milestone to pandemic-weary Californians: As of June 15, California public health guidelines that have been in place during the 15 months of the COVID-19 pandemic will be relaxed. Those who are fully vaccinated against COVID-19 will be able to go mask-free in most situations, but Cedars-Sinai infectious disease experts suggest masks, an important tool in preventing transmission of the virus, will be with us a while longer.

Released: 14-Jun-2021 9:45 AM EDT
People with Health Insurance Vaccinated More Than Those Without, Survey Finds
Rutgers University-New Brunswick

People with health insurance are receiving the COVID-19 vaccine at a higher rate than those without insurance, despite the vaccine being free, according to a national survey from the Edward J. Bloustein School of Planning and Public Policy at Rutgers University-New Brunswick.

Newswise: Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Released: 14-Jun-2021 8:55 AM EDT
Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

Newswise:Video Embedded study-links-covid-19-public-health-efforts-to-dramatic-drop-in-copd-hospitalizations
VIDEO
Released: 14-Jun-2021 8:00 AM EDT
Study Links COVID-19 Public Health Efforts to Dramatic Drop in COPD Hospitalizations
University of Maryland Medical Center

Public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: A 53 percent drop in hospital admissions for chronic obstructive pulmonary disease (COPD), likely due to a drop in circulating seasonal respiratory viruses such as influenza.


Showing results

110 of 5820

close
2.72787